Emerson is compounding on power and testing demand, but at $163.50 the stock needs flawless growth. I see 5% upside to $171.60.
Key points
- $1.71 of adjusted EPS in fiscal Q3 FY26 rose 13% from last year on 6% sales growth in the quarter.
- $12.4 billion of project funnel in July 2026 grew 8% from last year with power at $3.0 billion and LNG at $2.2 billion.
- $13.1 billion of debt at June 30 2026 against $2.2 billion of cash caps buyback upside.
The call
The business is strong but the price asks for a lot. At $163.50 Emerson trades at 25 times $6.55 of fiscal 2026 adjusted profit. That price needs fast growth with margins near 28% to pay off.
Revenue is reaccelerating into Q4SEC XBRL facts to Q3 FY26; Q4 FY26E yours.
I expect growth that falls a bit short. I see $7.15 of fiscal 2027 adjusted profit on 4.5% sales growth for the year. Soft China and uneven software renewals limit upside from here.
Valuation
| Driver | Estimate |
|---|
| Fiscal 2026 sales | $18.9 billion |
| Fiscal 2027 sales | $19.8 billion |
| Fiscal 2027 adjusted profit per share | $7.15 |
| Target multiple | 24 times |
| Target | $171.60 a share |
Adjusted profit means profit without one time items. A 24 multiple fits 9% profit growth in fiscal 2027 with a 3.9% cash yield for the year. With 5% price upside to target, a hold matches the reward and risk.
Target needs a full multiple to beat the marketMy arithmetic on $7.15 FY27E EPS; price $163.50 Oct 13 2026.
Risks
- Middle East work stays slow and project shipments slip, which you would see in orders divided by sales falling below 1.0.
- China and Europe stay weak and chemical spending stalls, which you would see in flat orders for two quarters.
- Software contract value stalls on weak renewals, which you would see in yearly contract value growth below 10% in fiscal 2027.
What would change my mind
I would turn positive if orders hold above 7% while China returns to growth and cash flow stays above profit.